期刊
INTERNATIONAL NANO LETTERS
卷 7, 期 2, 页码 91-122出版社
SPRINGER INT PUBL AG
DOI: 10.1007/s40089-017-0208-0
关键词
Degenerative diseases; Nanotechnology; Nanocarrier; Biocompatibility; Drug delivery; Drug resistance; Drug development; Bioavailability; Blood-brain barrier
资金
- Kalasalingam University, Krishnankoil, India
- Department of Chemical Engineering, Jadavpur University, Kolkata, India
Degenerative diseases are results of deterioration of cells and tissues with aging either by unhealthy lifestyle or normal senescence. The degenerative disease likely affects central nervous system and cardiovascular system to a great extent. Certain medications and therapies have emerged for the treatment of degenerative diseases, but in most cases bearing with poor solubility, lower bioavailability, drug resistance, and incapability to cross the blood-brain barrier (BBB). Hence, it has to be overcome with conventional treatment system; in this connection, nanotechnology has gained a great deal of interest in recent years. Moreover, nanotechnology and nanocarrier-based approach drug delivery system could revolutionize the treatment of degenerative diseases by faster absorption of drug, targeted interaction at specific site, and its release in a controlled manner into human body with minimal side effects. The core objective of this review is to customize and formulate therapeutically active molecules with specific site of action and without affecting other organs and tissues to obtain effective result in the improvement of quality of health. In addition, the review provides a concise insight into the recent developments and applications of nanotech and nanocarrier-based drug delivery for the treatment of various degenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据